Recent Comments

Comment RSS

Roxane Laboratories receives ANDA approval for Perindopril Erbumine Tablets

11. November 2009 00:32

Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration. The product is available in bottles of 100 for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories' Perindopril Erbumine Tablets are AB rated to ACEON® (perindopril erbumine) tablets. Annual sales of ACEON® are approximately $24.1 Million.

SOURCE Roxane Laboratories, Inc.

Posted in: Pharmaceutical News

Tags: ,

Permalink | Comments (0)
Bookmark
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment



(Will show your Gravatar icon)
  Country flag


biuquote
  • Comment
  • Preview
Loading



News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.